Catalyst Wire Dossier Catalyst Wire Dossier

DEBIRI

irinotecan-loaded drug-eluting beads
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DEBIRI, covering 2015-05-13 to 2015-05-13. Get the full timeline:

Most recent: Clinical Trial Update: Observational Study on Second Line Treatment of Liver Metastases With DEBIRI and Cetuximab

See pricing